Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Sabra Health Care REIT, Inc.SBRA · Entity 886 | Executive VP, CFO & Secretary | December 29, 2021 | December 30, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Sabra Health Care REIT, Inc.
Report date December 29, 2021 · Filed December 30, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 474,693 |
Reported balance
After 2021-12-29 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2021-12-29 · Sale · Disposed 110,000 · Balance 474,693 F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.5300 to $13.6150, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2: Includes 247,167 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.5300 to $13.6150, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2: Includes 247,167 stock units that, upon settlement, will be paid on a one-for-one basis in shares of the Issuer's Common Stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 28, 2017 Filed Mar 2, 2017 22:59 UTC | Sabra Health Care REIT, Inc. SBRA · Entity 886 | GrantCommon Stock | 701 | $0.00 | $0.00 |
DisclosureSEC source: 0001510192-17-000019 · wf-form4_148849554656928.xml · nonDerivative · entry 1 Andrews Harold W. Jr. · CIK 0001505081 · Executive VP, CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 253,723 F1 · shares: Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate. Read SEC document |
| December 31, 2016 Filed Jan 5, 2017 01:08 UTC | Sabra Health Care REIT, Inc. SBRA · Entity 886 | Tax withholdingCommon Stock | 3,165 | $24.42 | $77,289.30 |
DisclosureSEC source: 0001510192-17-000007 · wf-form4_148357846963109.xml · nonDerivative · entry 1 Andrews Harold W. Jr. · CIK 0001505081 · Executive VP, CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 253,022 F1 · shares: Represents shares withheld by the Issuer in accordance with Rule 16b-3 to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person. F2 · balance_after: Includes 45,426 unvested stock units that, upon vesting, will be paid on a one-for-one basis in shares of the Issuer's Common Stock. Read SEC document |
| December 16, 2016 Filed Dec 21, 2016 02:09 UTC | Sabra Health Care REIT, Inc. SBRA · Entity 886 | GrantCommon Stock | 16,055 | $0.00 | $0.00 |
DisclosureSEC source: 0001510192-16-000158 · wf-form4_148228613392950.xml · nonDerivative · entry 1 Andrews Harold W. Jr. · CIK 0001505081 · Executive VP, CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 256,187 F1 · shares: Grant of stock units under the Issuer's 2009 Performance Incentive Plan (the "Plan"). The units vest at the rate of 25% on each of December 31, 2017, December 31, 2018, December 31, 2019, and December 31, 2020. The vested units will be paid on a one-for-one basis in shares of the Issuer's Common Stock in the 2021 calendar year, subject to earlier payment in the event of separation from service, death, disability or change of control. F2 · balance_after: Includes 53,061 unvested stock units that, upon vesting, will be paid on a one-for-one basis in shares of the Issuer's Common Stock. Read SEC document |
| November 30, 2016 Filed Dec 3, 2016 02:24 UTC | Sabra Health Care REIT, Inc. SBRA · Entity 886 | GrantCommon Stock | 689 | $0.00 | $0.00 |
DisclosureSEC source: 0001510192-16-000151 · primary_doc.xml · nonDerivative · entry 1 Andrews Harold W. Jr. · CIK 0001505081 · Executive VP, CFO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 240,132 F1 · shares: Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate. F2 · balance_after: Includes 37,006 unvested stock units that, upon vesting, will be paid on a one-for-one basis in shares of the Issuer's Common Stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.